Core Viewpoint - Newmont Corporation (NEM) has significantly outperformed the broader market and is experiencing strong growth in earnings potential due to rising gold prices. Group 1: Company Overview - Newmont Corporation is a gold mining company based in Denver, Colorado, with a market capitalization of $144 billion, primarily focused on gold production and also involved in copper, silver, zinc, and lead as by-products [1]. Group 2: Stock Performance - Over the past 52 weeks, NEM shares have increased by 219.1%, while the S&P 500 Index has only gained 15%. Year-to-date, NEM is up 32.2%, compared to the S&P 500's 1.9% return [2]. - NEM has outperformed the VanEck Gold Miners ETF (GDX), which rose 197.5% over the past 52 weeks and 30.8% year-to-date [3]. Group 3: Market Reaction and Earnings Potential - On January 28, NEM shares rose by 3.9% as gold prices surged over 3% to a new all-time high, enhancing investor optimism regarding the miners' earnings potential, cash flows, and margins [4]. - For the current fiscal year ending in December, analysts project NEM's earnings per share (EPS) to grow by 81.9% year-over-year to $6.33, with a strong earnings surprise history [5]. Group 4: Analyst Ratings and Price Targets - Among 23 analysts covering NEM, the consensus rating is a "Strong Buy," with 17 "Strong Buy," two "Moderate Buy," and four "Hold" ratings [5]. - The Bank of Nova Scotia has maintained an "Outperform" rating on NEM and raised its price target to $152, indicating a potential upside of 15.2% from current levels, while the stock is trading above its mean price target of $119.83 [6].

Core Viewpoint - Gilead Sciences, Inc. has demonstrated strong stock performance driven by new product approvals and pipeline advancements, particularly in the HIV treatment sector, positioning the company favorably in the biopharmaceutical market [2][4]. Financial Performance - Gilead reported Q3 revenue of $7.8 billion, reflecting a 3% year-over-year increase, with adjusted EPS at $2.47, up 22.3% from the previous year [5]. - For the fiscal year ending December 2025, analysts project Gilead's EPS to grow by 76.4% to $8.15 on a diluted basis [6]. Stock Performance - Over the past year, Gilead's stock has increased by 48.9%, significantly outperforming the S&P 500 Index, which rose nearly 15% [2]. - Year-to-date, Gilead's stock is up 13.8%, compared to a 1.9% increase in the S&P 500 [2]. Analyst Ratings - Among 30 analysts covering Gilead, the consensus rating is a "Strong Buy," with 22 "Strong Buy" ratings, two "Moderate Buys," and six "Holds" [6]. - Truist Financial Corporation has maintained a "Buy" rating on Gilead and raised the price target to $145, indicating a potential upside of 3.8% from current levels [7]. Market Position - Gilead's strong performance is attributed to the FDA approval and rollout of the HIV prevention drug Yeztugo, which is expected to enhance market potential and investor confidence [4]. - Compared to the Invesco Pharmaceuticals ETF, which gained about 21.7% over the past year, Gilead's performance highlights its competitive edge in the biopharmaceutical sector [3].

Core Viewpoint - Truist Financial Corporation (TFC) is a significant player in the financial services sector, with a market capitalization of $65.1 billion, offering a wide range of banking and financial services [1] Performance Summary - TFC shares have underperformed compared to the broader market over the past year, gaining 6.4% while the S&P 500 Index increased nearly 15%. However, in 2026, TFC stock has risen 2.2%, slightly outperforming the SPX's 1.9% increase year-to-date [2] - TFC's performance aligns closely with the SPDR S&P Regional Banking ETF (KRE), which has also gained about 6.4% over the past year, with a year-to-date increase of 4.6% [3] Financial Results - On January 21, TFC reported its Q4 results, with revenue of $5.25 billion, which was 1.3% below analyst expectations. The company's earnings per share (EPS) of $1 exceeded analyst forecasts of $1.09 [4] - For the current fiscal year ending in December, analysts project TFC's EPS to grow by 13.4% to $4.48 on a diluted basis. The company's earnings surprise history shows mixed results, beating consensus estimates in three of the last four quarters [4] Analyst Ratings - Among 22 analysts covering TFC, the consensus rating is a "Moderate Buy," consisting of eight "Strong Buy" ratings, two "Moderate Buys," 11 "Holds," and one "Strong Sell" [5] - The analyst outlook has become more bullish compared to the previous month, with seven analysts now suggesting a "Strong Buy." Argus maintained a "Buy" rating on TFC and raised the price target to $58, indicating a potential upside of 15.3% from current levels. The mean price target is $55.81, representing a 10.9% premium to TFC's current price, while the highest price target of $63 suggests an upside potential of 25.2% [6]

Core Viewpoint - StoneCo Ltd. has been downgraded by Santander from "Outperform" to "Neutral," indicating a more cautious outlook on the stock despite recent positive performance in the market [1][6]. Company Performance - At the time of the downgrade, StoneCo's stock was priced at $16.99, closing at $16.59, which represents a 1.9% increase from the previous session, outperforming the S&P 500 and Dow [2]. - Over the past month, StoneCo's stock has surged by 9.7%, significantly outperforming the Computer and Technology sector's gain of 0.49% and the S&P 500's increase of 0.38% [3][6]. - The company's market capitalization is approximately $4.55 billion, with a trading volume of 5,509,215 shares, and the stock has fluctuated between a low of $16.38 and a high of $17.04 on the day of reporting [5]. Upcoming Earnings Report - Investors are anticipating StoneCo's upcoming earnings report on March 2, 2026, with analysts predicting earnings of $0.5 per share, reflecting a year-over-year growth of 28.21% [4]. - The consensus estimate for revenue is $749 million, indicating a 21.29% increase from the same quarter last year [4].

Core Insights - Merchants Bancorp (MBIN) reported a revenue of $185.29 million for the quarter ended December 2025, reflecting a decrease of 4.4% year-over-year, while EPS was $1.28 compared to $1.85 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $171.87 million by 7.81%, and the EPS surpassed the consensus estimate of $0.94 by 36.17% [1] Financial Performance Metrics - Efficiency Ratio stood at 45.1%, slightly better than the average estimate of 45.6% from three analysts [4] - Net interest margin was reported at 2.9%, above the average estimate of 2.8% from three analysts [4] - Average Earning Assets totaled $18.93 billion, exceeding the average estimate of $18.3 billion from three analysts [4] - Tier I capital/risk-weighted assets Ratio was 13.1%, compared to the estimated 13% by two analysts [4] - Total capital/risk-weighted assets Ratio was 13.6%, slightly below the estimated 13.7% by two analysts [4] - Net Interest Income reached $138.09 million, surpassing the average estimate of $129.39 million from three analysts [4] - Gain on Sale of Loans was $25.73 million, exceeding the average estimate of $24.82 million from three analysts [4] - Total Noninterest Income was reported at $47.2 million, above the average estimate of $42.49 million from three analysts [4] - Other income was $9.76 million, significantly higher than the average estimate of $4.62 million from three analysts [4] Stock Performance - Shares of Merchants Bancorp have returned +4.9% over the past month, outperforming the Zacks S&P 500 composite's +0.8% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Metro Inc. is a significant player in the Canadian retail and food industry, operating supermarkets, discount stores, and pharmacies, and competes with major retailers like Loblaw Companies and Sobeys [1] Financial Performance - BMO Capital maintained an "Outperform" rating for Metro Inc. (MTRAF) while adjusting the price target from C$115 to C$110, with the stock price at $68.73, reflecting a slight increase of 0.37% [2] - The recent Q1 2026 earnings call highlighted the company's financial health, discussing earnings, revenue growth, and strategic plans, with the stock price showing stability within the trading range [3] Market Position - MTRAF has a 52-week high of $78.73 and a low of $62.30, indicating volatility over the past year, with a market capitalization of approximately $14.7 billion [4] - The trading volume for MTRAF is 627 shares, making it a stock of interest for investors in the retail sector [4]

Core Viewpoint - Venture Global (NYSE:VG) is facing a legal dispute with Shell, which is impacting its stock performance and market perception, yet RBC Capital maintains an "Outperform" rating for the company [1][5]. Company Overview - Venture Global is a U.S.-based liquefied natural gas (LNG) producer with a current market capitalization of approximately $21.9 billion [3]. Stock Performance - The stock price of VG is currently at $8.95, reflecting a slight increase of 0.46% or $0.04 from the previous day [2][5]. - VG's stock has fluctuated between a high of $22.14 and a low of $5.72 over the past year, indicating significant volatility in the market [3]. Trading Activity - The trading volume for VG is reported at 1,723,339 shares, suggesting active investor interest and close monitoring of the company's legal situation [4][5]. Analyst Ratings - RBC Capital has adjusted its price target for VG from $13 to $11, citing ongoing legal issues and market conditions as the reasons for this adjustment [2][5].

Nothing can bring down Tesla Inc. (NASDAQ: TSLA) stock. ...

Core Insights - Walmart Inc. has a market capitalization of $932 billion and operates through three segments: Walmart U.S., Walmart International, and Sam's Club, offering a wide range of products and services globally [1] Performance Overview - Over the past 52 weeks, Walmart's stock has increased by 20.1%, outperforming the S&P 500 Index, which gained 16.1% [2] - Year-to-date, Walmart shares are up nearly 5%, compared to a 1.9% rise in the S&P 500 [2] Competitive Position - Walmart's stock has outperformed the State Street Consumer Staples Select Sector SPDR ETF, which returned 3.9% over the past 52 weeks [3] Financial Results - In Q3 2026, Walmart reported a revenue increase of 5.8% to $179.5 billion and an adjusted EPS rise of 6.9% to $0.62, driven by strong e-commerce performance with global online sales up 27% and advertising revenue up 53% [4] - U.S. comparable sales grew by 4.5%, while international sales increased by 10.8% [4] Future Guidance - Walmart raised its fiscal 2026 guidance, expecting net sales growth of 4.8% to 5.1% and adjusted EPS between $2.58 and $2.63 [5] - Analysts project a 4.8% year-over-year growth in adjusted EPS to $2.63 for the fiscal year ending January 2026 [5] Analyst Sentiment - The consensus rating among 38 analysts is a "Strong Buy," with 29 "Strong Buy" ratings, six "Moderate Buys," two "Holds," and one "Strong Sell" [6] - The bullish sentiment has slightly decreased from three months ago when there were 31 "Strong Buys" [7] - Tigress Financial raised Walmart's price target to $135 while maintaining a "Buy" rating [7]

Core Insights - Boston Properties (BXP) reported revenue of $809.15 million for the quarter ended December 2025, reflecting a year-over-year increase of 1.4% but a revenue surprise of -0.68% compared to the Zacks Consensus Estimate of $814.66 million [1] - The company's EPS was $1.56, significantly higher than the $0.49 reported in the same quarter last year, but fell short of the consensus estimate of $1.80, resulting in an EPS surprise of -13.52% [1] Financial Performance Metrics - The occupancy rate of in-service properties was reported at 86.7%, slightly exceeding the average estimate of 86.3% from three analysts [4] - Revenue from parking and other services, including insurance proceeds, was $42.88 million, surpassing the average estimate of $35.1 million from five analysts, marking a year-over-year increase of 25.9% [4] - Revenue from development and management services was $8.64 million, slightly below the average estimate of $9.04 million from five analysts, representing a year-over-year decrease of 1.6% [4] - Hotel revenue was reported at $12.46 million, which was lower than the average estimate of $13.71 million from four analysts, indicating a year-over-year decline of 5.2% [4] - The lease revenue of $809.15 million was compared to the average estimate of $814.61 million based on four analysts, showing a year-over-year increase of 1.4% [4] - The diluted net earnings per share were reported at $1.56, significantly higher than the average estimate of $0.59 from five analysts [4] Stock Performance - Over the past month, shares of Boston Properties have returned -6.1%, contrasting with a +0.4% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]